[1]Mcgrath KE, Frame JM, Palis J. Early hematopoiesis and macrophage development\[J\]. Semin Immunol, 2015, 27(6): 379-387.
[2]Murray PJ. Macrophage polarization\[J\]. Annu Rev Physiol, 2017, 79: 541-566.
[3]Sica A, Erreni M, Allavena P, et al. Macrophage polarization in pathology\[J\]. Cell Mol Life Sci, 2015, 72(21): 4111-4126.
[4]Ngambenjawong C, Gustafson HH, Pun SH. Progress in tumorassociated macrophage (TAM)targeted therapeutics\[J\]. Adv Drug Deliv Rev, 2017, 114: 206-221.
[5]Chen LL. Linking long noncoding RNA localization and function\[J\]. Trends Biochem Sci, 2016, 41(9): 761-772.
[6]Aune TM, Spurlock CF 3rd. Long noncoding RNAs in innate and adaptive immunity\[J\]. Virus Res, 2016, 212: 146-160.
[7]Soysal SD, Tzankov A, Muenst SE. Role of the tumor microenvironment in breast cancer\[J\]. Pathobiology, 2015, 82(3-4): 142-152.
[8]Aras S, Zaidi MR. TAMeless traitors: macrophages in cancer progression and metastasis\[J\]. Br J Cancer, 2017, 117(11): 1583-1591.
[9]Kitamura T, Qian BZ, Soong D, et al. CCL2induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasisassociated macrophages\[J\]. J Exp Med, 2015, 212(7): 1043-1059.
[10]Luput L, Licarete E, Sesarman A, et al. Tumorassociated macrophages favor C26 murine colon carcinoma cell proliferation in an oxidative stressdependent manner\[J\]. Oncol Rep, 2017, 37(4): 2472-2480.
[11]Mathy NW, Chen XM. Long noncoding RNAs (lncRNAs) and their transcriptional control of inflammatory responses\[J\]. J Biol Chem, 2017, 292(30): 12375-12382.
[12]Tang SS, Zheng BY, Xiong XD. LincRNAp21: Implications in human diseases\[J\]. Int J Mol Sci, 2015, 16(8): 18732-18740.
[13]Chen S, Liang H, Yang H, et al. LincRNAp21: function and mechanism in cancer\[J\]. Med Oncol, 2017, 34(5): 98. |